Celebrity-backed cancer treatment venture eyes London listing
A cancer drug venture backed by a group of celebrity investors and Middle Eastern wealth is planning to list on the London Stock Exchange. Ellipses Pharma, a clinical-stage oncology venture founded by renowned British biotech entrepreneur Sir Chris Evans and, is preparing to reverse into a brand-new company, targeting a listing valuation of between £450m [...]
Full story
Read the full story at City A.M. ↗
Continue reading this story on City A.M., the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.